Prestige Consumer Healthcare Inc. (PBH)
USD 84.19
(2.38%)
USD 84.19
(2.38%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | 209.33 Million USD | 354.34% |
| 2023 | -82.3 Million USD | -140.07% |
| 2022 | 205.38 Million USD | 24.71% |
| 2021 | 164.68 Million USD | 15.74% |
| 2020 | 142.28 Million USD | 497.43% |
| 2019 | -35.8 Million USD | -110.54% |
| 2018 | 339.57 Million USD | 389.33% |
| 2017 | 69.39 Million USD | -30.54% |
| 2016 | 99.9 Million USD | 27.66% |
| 2015 | 78.26 Million USD | 7.77% |
| 2014 | 72.61 Million USD | 10.85% |
| 2013 | 65.5 Million USD | 76.03% |
| 2012 | 37.21 Million USD | 27.35% |
| 2011 | 29.22 Million USD | -9.01% |
| 2010 | 32.11 Million USD | 117.19% |
| 2009 | -186.77 Million USD | -650.65% |
| 2008 | 33.91 Million USD | -5.98% |
| 2007 | 36.07 Million USD | 37.3% |
| 2006 | 26.27 Million USD | 95.24% |
| 2005 | 13.45 Million USD | 221.75% |
| 2004 | 4.18 Million USD | 128.08% |
| 2003 | -14.89 Million USD | -2833.21% |
| 2002 | 545 Thousand USD | -78.44% |
| 2001 | 2.52 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 53.04 Million USD | -0.96% |
| 2024 Q4 | 49.45 Million USD | -6.76% |
| 2024 FY | 209.33 Million USD | 354.34% |
| 2024 Q1 | 53.27 Million USD | 122.15% |
| 2024 Q2 | 53.55 Million USD | 0.53% |
| 2023 Q2 | 51.02 Million USD | -7.69% |
| 2023 FY | -82.3 Million USD | -140.07% |
| 2023 Q4 | -240.55 Million USD | -563.04% |
| 2023 Q3 | 51.95 Million USD | 1.82% |
| 2023 Q1 | 55.27 Million USD | 6.12% |
| 2022 Q3 | 50.21 Million USD | 10.79% |
| 2022 FY | 205.38 Million USD | 24.71% |
| 2022 Q1 | 57.75 Million USD | 62.63% |
| 2022 Q2 | 45.32 Million USD | -21.52% |
| 2022 Q4 | 52.08 Million USD | 3.73% |
| 2021 Q2 | 44.58 Million USD | 2.02% |
| 2021 Q3 | 40.87 Million USD | -8.33% |
| 2021 Q1 | 43.7 Million USD | 17.98% |
| 2021 FY | 164.68 Million USD | 15.74% |
| 2021 Q4 | 35.51 Million USD | -13.11% |
| 2020 Q2 | 33.25 Million USD | -1.98% |
| 2020 Q4 | 37.04 Million USD | -2.66% |
| 2020 FY | 142.28 Million USD | 497.43% |
| 2020 Q1 | 33.92 Million USD | 124.36% |
| 2020 Q3 | 38.05 Million USD | 14.45% |
| 2019 Q4 | -139.27 Million USD | -464.91% |
| 2019 Q3 | 38.16 Million USD | 23.75% |
| 2019 Q2 | 30.84 Million USD | -10.52% |
| 2019 Q1 | 34.46 Million USD | 186.84% |
| 2019 FY | -35.8 Million USD | -110.54% |
| 2018 Q4 | -39.68 Million USD | -112.61% |
| 2018 FY | 339.57 Million USD | 389.33% |
| 2018 Q1 | 33.75 Million USD | 204.41% |
| 2018 Q2 | 30.7 Million USD | -9.05% |
| 2018 Q3 | 314.79 Million USD | 925.22% |
| 2017 Q4 | 11.09 Million USD | -64.95% |
| 2017 FY | 69.39 Million USD | -30.54% |
| 2017 Q3 | 31.64 Million USD | -1.72% |
| 2017 Q2 | 32.19 Million USD | 682.08% |
| 2017 Q1 | -5.53 Million USD | -139.69% |
| 2016 Q2 | 31.8 Million USD | 21.51% |
| 2016 Q4 | 13.93 Million USD | -50.22% |
| 2016 Q3 | 27.99 Million USD | -11.97% |
| 2016 FY | 99.9 Million USD | 27.66% |
| 2016 Q1 | 26.17 Million USD | 10.1% |
| 2015 FY | 78.26 Million USD | 7.77% |
| 2015 Q3 | 21.29 Million USD | 29.34% |
| 2015 Q1 | 16.73 Million USD | 4.57% |
| 2015 Q2 | 16.46 Million USD | -1.61% |
| 2015 Q4 | 23.77 Million USD | 11.64% |
| 2014 Q2 | 32.79 Million USD | 58.48% |
| 2014 Q4 | 16 Million USD | 411.21% |
| 2014 Q3 | 3.13 Million USD | -90.45% |
| 2014 FY | 72.61 Million USD | 10.85% |
| 2014 Q1 | 20.69 Million USD | 6.94% |
| 2013 Q3 | 12.25 Million USD | -36.31% |
| 2013 FY | 65.5 Million USD | 76.03% |
| 2013 Q4 | 19.34 Million USD | 57.86% |
| 2013 Q2 | 19.24 Million USD | 31.31% |
| 2013 Q1 | 14.65 Million USD | 97800.0% |
| 2012 Q4 | -15 Thousand USD | -100.16% |
| 2012 Q1 | 14.76 Million USD | 130.25% |
| 2012 Q2 | 12.94 Million USD | -12.32% |
| 2012 FY | 37.21 Million USD | 27.35% |
| 2012 Q3 | 9.51 Million USD | -26.56% |
| 2011 Q2 | 11.02 Million USD | 14.75% |
| 2011 Q1 | 9.6 Million USD | 192.21% |
| 2011 Q4 | 6.41 Million USD | 194.49% |
| 2011 Q3 | 2.17 Million USD | -80.24% |
| 2011 FY | 29.22 Million USD | -9.01% |
| 2010 Q2 | 9.92 Million USD | 19.2% |
| 2010 Q4 | 3.28 Million USD | -68.93% |
| 2010 FY | 32.11 Million USD | 117.19% |
| 2010 Q1 | 8.32 Million USD | 103.94% |
| 2010 Q3 | 10.58 Million USD | 6.62% |
| 2009 Q2 | 8.52 Million USD | 9.52% |
| 2009 Q3 | 8.01 Million USD | -5.91% |
| 2009 FY | -186.77 Million USD | -650.65% |
| 2009 Q4 | -211.09 Million USD | -2732.79% |
| 2009 Q1 | 7.78 Million USD | -24.83% |
| 2008 Q4 | 10.35 Million USD | 22.95% |
| 2008 Q2 | 6.82 Million USD | -17.92% |
| 2008 Q3 | 8.41 Million USD | 23.28% |
| 2008 Q1 | 8.32 Million USD | -0.89% |
| 2008 FY | 33.91 Million USD | -5.98% |
| 2007 Q1 | 8.25 Million USD | 127.5% |
| 2007 Q2 | 8.78 Million USD | 6.4% |
| 2007 Q3 | 10.64 Million USD | 21.16% |
| 2007 Q4 | 8.39 Million USD | -21.12% |
| 2007 FY | 36.07 Million USD | 37.3% |
| 2006 Q1 | 4 Million USD | 1888.84% |
| 2006 Q4 | 3.62 Million USD | -61.17% |
| 2006 Q2 | 7.37 Million USD | 84.03% |
| 2006 Q3 | 9.34 Million USD | 26.73% |
| 2006 FY | 26.27 Million USD | 95.24% |
| 2005 Q1 | -5.13 Million USD | 0.0% |
| 2005 Q2 | 9.67 Million USD | 288.3% |
| 2005 FY | 13.45 Million USD | 221.75% |
| 2005 Q3 | 9.14 Million USD | -5.44% |
| 2005 Q4 | -224 Thousand USD | -102.45% |
| 2004 FY | 4.18 Million USD | 128.08% |
| 2003 FY | -14.89 Million USD | -2833.21% |
| 2002 FY | 545 Thousand USD | -78.44% |
| 2001 FY | 2.52 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Cardinal Health, Inc. | 852 Million USD | 75.43% |
| Cencora | 1.5 Billion USD | 86.128% |
| McKesson Corporation | 3 Billion USD | 93.027% |
| Owens & Minor, Inc. | -41.3 Million USD | 606.862% |